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ABSRACT 
Background: Congenital Rubella Infection can be prevented and future generation saved from disability by protecting 
women of reproductive age through vaccination. The study is aimed at determining serological evidence of recent rubella 
infection among women of childbearing age. 
Method: A cross sectional study was carried out among 285 women aged between 15 and 49 years. Enzyme immunoassay 
method was used to detect and quantify human IgM and IgG antibodies with avidity for Rubella virus in sera of 
participants. Socio-demographic characteristics of the subjects, along with recent history of fever, rash and adverse 
pregnancy outcome among others were obtained using a questionnaire. Statistical analysis was carried out using the 
program statistical package for social sciences (SPSS) version 16.  
Majority (78.3%) of the women recruited for the study were within 15-34 years age range. Of the 285 sera assayed for 
Rubella IgM antibodies, 23 (8.1%; 95% CI: 4.9%-11.3 %.) was IgM seropositive, while the remaining 262 (91.9%) were 
seronegative. 
 A total of 7 (2.5%) of reproductive age women in Ilorin had a recent primary infection while 16 (5.6%) had a persistent 
Rubella infection or recent re-infection. 
In conclusion, there is need for vaccination of susceptible women of reproductive age in Ilorin as a large number of women 
have Rubella in their reproductive age. 
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RESUME  
Content  : L’infection Rubéole congénitale peut être évitée et la future génération  sauvée de l’invalidité en protégeant les femmes en 
âge de procréer par la vaccination. L’étude vise à déterminer la présence l’infection de rubéole récente chez les femmes d’âge de 
procréer. 
Méthode  : Une étude transversale a été réalisée parmi 285 femmes âgées de 15 à 49 ans. La méthode enzyme 
immunoassay a été utilisée pour détecter et quantifier les anticorps IgM et IgG humaines avec avidité pour le virus rubéole dans 
les sérums des participants. Les caractéristiques  socio  – démographiques  des sujets,  avec l’histoire récente de la fièvre, 
l’éruption cutanée, résultats défavorables de la grossesse entre autres choses ont été obtenus en utilisant un questionnaire. 
L’analyse statistique a été effectuée en utilisant le progiciel statistique  pour les sciences sociales (SPSS) version 16. 
La plupart des femmes (78,3%) recrutées pour l’étude ont été dans les 15 – 34 tranches d’âge.  Sur les 285 sérums testés 
pour les anticorps IgM de la rubéole, 23 (8,1% ; 95% CI : 4,9% - 11,3%) était IgM séropositive, alors que les autres 262 (91,9%) étaient 
séronégatives. Un totale de 7 femmes d’âge de procréer à Ilorin avaient une infection primaire récente alors que 16 (5,6%) avaient 




En conclusion, il est nécessaire de vacciner des femmes en âge de procréer qui  ont sensibles à Ilorin  comme un grand 
nombre de femmes a eu la rubéole leur âge de procréer. 
Mots clés: Rubéole, immunoglobuline M, avidité, âge de procréer, Ilorin, Nigeria. 
 
INTRODUCTION 
Rubella is a significant cause of vaccine preventable 
birth defects. It is caused by Rubella virus, the only 
member of the Rubivirus genus of the Togaviridae 
family of RNA viruses (1). Rubella virus is spread 
mostly by droplets from upper respiratory tract (2). 
If acquired in pregnancy – especially in the first 
trimester - serious consequences may ensue in up to 
90% of cases including miscarriage, foetal death, 
still birth and congenital rubella syndrome (3). 
Congenital Rubella Syndrome (CRS) affects 
virtually all organ systems and can lead to 
blindness, deafness, heart diseases and many others 
manifestations (4). Approximately the global 
burden of CRS is 110,000 cases annually (ranges 
between 14,000 and 308,000), with highest burden 
in the World Health Organization (WHO) South-
east Asian (approximately 48%) and African 
(approximately 38%) regions (5).  Although data on 
CRS in Africa are very limited and the true burden 
is largely unknown, the burden of the chronic 
disabilities from CRS is high as these disabilities 
incur high treatment costs thus increasing the 
public health importance of Rubella (6).  
Rubella infections occur worldwide. The 
seroprevalence varies widely between countries, 
different parts of the same country and overtime 
within a particular region of a country. (7) The 
highest risk of CRS is found in countries with high 
susceptibility (low seroprevalence) rates among 
women of childbearing age, as presence of high 
circulating maternal antibody (minimum serum 
Rubella IgG level of 10-15 IUml-1) indicates 
immunity to Rubella and virtually excludes the 
possibility of transmission of Rubella to the foetus 
(8). 
Congenital Rubella syndrome occurrences are now 
rare in most developed countries, since the 
introduction of rubella vaccine (9). Various sero-
epidemiological studies have evaluated the 
prevalence of rubella IgM in developing world. The 
rubella IgM seroprevalence among women of 
childbearing age is reported as 0.97% in Turkey and 
ranged from 5.1% to 9.6% in South African Province 
(10, 11) Five percent of all reported Rubella 
infection in Africa occur in women of reproductive 
age (12). 
Rubella is endemic in Nigeria. Studies among 
women of child bearing age in Nigeria put IgM 
seroprevalence at 9.2% in Benin City, 3.9% and 
3.26% in Markudi and Ilorin respectively (13, 14, 
15).  Unfortunately, routine screening of antenatal 
women for Rubella immunity is not available and 
there is no national surveillance on rubella in the 




member states, Nigeria is yet to include Rubella-
containing vaccines in their routine immunization 
programmes (16).  
It has been estimated that to prevent CRS the 
percentage of susceptible women of child-bearing 
age must not exceed 5.0% (12). A recent study in 
this environment however put the seroprevalence 
of Rubella among pregnant women at 16.3% (15). 
Rubella infection especially among women of 
reproductive age needs to be assessed with a view 
to ascertaining the risk of CRS. This study therefore 
aim to determine serological evidence of recent 
rubella infection among women of reproductive 
age, since this age group are important in 
determining those at risk of bearing babies with 
CRS. 
MATERIAL AND METHODS 
Study Population 
All consecutive women of reproductive age (15-49 
years) seen at the general out-patient department 
(GOPD) UITH, Ilorin were enrolled. Patient who do 
not consent, pregnant women and those with 
history of previous Rubella immunization were 
excluded. Ethical clearance was obtained from the 
Ethics and research committee of UITH Ilorin and 
informed consent was obtained from each 
participant 
Method of data collection  
Demographic and socio-economic information of 
participants such as age, marital status, religion, 
occupation, level of education and monthly family 
income were recorded in a questionnaire 
specifically designed for the study which was 
administered in an interview based manner.  
Blood specimen collection and storage   
The blood samples were collected by venepuncture 
under aseptic condition. The blood was allowed to 
clot and retract at room temperature. Sera were 
separated by centrifugation at 3,000 rpm for 5 
minutes. The supernatant sera were aspirated into 
cryotubes using micropipette and stored at -200C 
until analysis.  
Laboratory tests   
 Rubella IgM, IgG and IgG-avidity were assayed for 
using RUB IgG (quantitative), RUB IgM 
(qualitative) and RUB Avidity (qualitative) kits 
215 
 
manufactured by Dia Pro. Diagnostic Bioprobes Srl 
Columella Milano, Italy (17). The tests were 
performed according to the manufacturer’s 
instructions. 
 
Interpretation of results  
 Rubella IgM:  Any sera with values of >1.2 was 
considered positive for Rubella IgM antibody and 
values of <1.0 was considered negative for Rubella 
IgM antibody. Values between 1.0 and 1.2 were 
considered as equivocal. 
Rubella IgG:  Any sera with antibodies >10 WHO 
IUml-1 were considered positive for Rubella IgG 
antibody and antibodies <10 WHO IUml-1 were 
considered negative for Rubella IgG antibody.  
Rubella IgG avidity test: Avidity index of > 0.4 
was considered high avidity IgG antibodies and 
indicates past infection (> 3 months previous) or re-
infection. Avidity index of < 0.4 was considered low 
avidity indicating a recent infection. 
Data analysis 
All data were entered into computer and analyzed 
using SPSS (Statistical Package for Social Sciences) 
version 16. Age of the participants was grouped 
into 15-24 years, 25-34 years, 35-44 years, and those 
above 44 years. Comparison of categorical data was 
done by Chi- square (χ2) and Fisher’s exact test. 
Results were presented in tables and figures where 
applicable. 
RESULTS 
Of the 285 subjects, only 23 participants were 
seropositive for Rubella specific IgM antibody. The 
seroprevalence of Rubella IgM antibodies was 8.1% 
(95% CI: 4.9%-11.3%). All the 23 participants with 
Rubella specific IgM antibodies also had Rubella 
specific IgG antibodies. Seven (2.5%) of the IgM 
seropositive participants had low-avidity IgG 
antibodies, implying recent primary infections 
while the remaining 16 (5.6%) had high-avidity IgG 
antibodies implying recent re-infections as shown 
in Figure I.  
A breakdown of the Rubella IgM seropositive 
participants with respect to their age groups is 
shown in table I. It revealed that the age groups 35-
44years had the lowest IgM seropositivity rate 
(5.4%). There is no significant association between 
age and Rubella specific IgM seropositivity (p-
0.689). 
As shown in table II, 49 women had a recent history 
of rash and fever (within the past 2 months), 3 
(6.1%) of them had Rubella specific IgM antibodies. 
Among the remaining 236 participants with no 
history of fever and rash, 20 (8.5%) had Rubella 
specific IgM antibodies. Therefore, no significant 
relationship was found between recent Rubella 
infection and recent history of fever and rash 
(p=0.776). 
 
TABLE I: STRATIFIED-AGE DISTRIBUTION OF RUBELLA IGM ANTIBODIES 
Variable  Rubella IgM 
Positive (%)*     Negative (%)* 







   8(7.5) 
  11(9.4) 
  3(5.4) 
  1(16.7) 
  
     98(92.5) 
    106(90.6)  
    53(94.6) 











   
*Row percentage 
TABLE II: RECENT HISTORY OF FEVER AND RASH BY RUBELLA-SPECIFIC IGM ANTIBODIES 
History of   Rubella specific IgM                                                 
fever & rash     Positive (%)  Negative (%)   OR(95%CI)          p-value** 
Yes    3(6.1)     46 (93.9) 
No    20(8.5)   216(91.5) 
Total   23(8.1) 262 (91.9) 0.72(0.22-2.34) 0.776 
OR- Odd ratio at 95% Confidence interval           ** - Fisher exact test 
 
Rubella specific IgM seropositivity of participants 
in relation to their specific occupation and level of 
education is presented in table III. The highest 
number of IgM seropositivity was observed among  
 
students and those whose highest level of education 
was secondary education. There was however, no 
significant association between Rubella IgM 




TABLE III: SERUM RUBELLA IGM BY SOME SOCIO
Variables   
   Positive (%)*
 
Level of education 
None          
Primary                        
Secondary         
Tertiary                          
 
Occupation 
Trading                         
Students                       12(9.2)
Civil servants              
Skilled labourers                       
House wife         
Unemployed         
*Row percentage   
 
 




Congenital Rubella Syndrome is a devastating 
consequence of maternal Rubella infection during 
early pregnancy. Thus women of reproductive age 
with recent primary rubella infection could be at 
risk of having CRS children, if they were to be 
pregnant.  
Detection of IgM antibody is well established as a 
means of diagnosing recent Rubella/CRS and is 
recommended by WHO as the primary test for 
laboratory confirmation of Rubella Infection (18). 
In this study, of the 285 subjects, 23 (8.1%) were 
seropositive for Rubella IgM antibodies, which 
indicate recent Rubella infections. In Nigeria, 
Rubella is currently not a notifiable disease and 
there is no routine surveillance for Rubella, thus 
pattern of wild Rubella virus circulation are not 
known (12). Five percent of all reported Rubella 
infection in Africa is said to occur in women of 
reproductive age (12). Similar Rubella IgM 
seropositivity of 9.2%, 6.8% and 6.5% among 







 Negative (%)* χ2  p-value
1(100.0)   13(0.0) 
 1(3.7)   26(96.3) 
13(8.0)   149(92.0) 
 8(9.2)   4(90.2)  1.025  0.795 
4(5.6)    67(94.4) 
    118(90.8) 
6(9.5)    57(90.5) 
 1(6.3)    15(93.7) 
0(0.0)    1(100.0) 
0(0.0)    4(100.0) 1.494  0.914 
 
     SEROPOSITIVE SUBJECTS 
 
Onakewhor et al, Singla et al. and Raveenran
(13, 19, 20). The 8.1% Rubella IgM seropositivity 
obtained in this study however differs fro
3.26% and 3.90% observed in previous study among 
pregnant women in Ilorin and Makurdi respectively 
(14, 15). The observed difference might be due to 
differences in study population and sample size.
Reliable serological diagnosis of rubella
requires discrimination of specific IgM
primary rubella from persistent, reinfection or non
specific IgM reactivity. To distinguish participants 
with reinfection or persistent infection from those 
with primary infection, since there were no pre
screening sera available, the rubella IgG avidity 
were determined. Sera from cases of recent rubella 
primary infection have low IgG avidity, while sera 
taken from participants with distant infection, 
including cases of rubella reinfection, have higher 






















Among the 23 participants with Rubella specific 
IgM antibodies only 7 (2.5%) had low-avidity 
Rubella IgG implying recent primary infections. Of 
this 7 participant only 3 (42.9%) had a recent history 
of fever and rash which might be due to the fact 
that more than 50% of Rubella infection can be 
subclinical (8). This particular proportion of women 
in their repoductive age had a chance of having a 
child with CRS if they were to be in early stage of 
pregnancy.  
Furthermore, because this study is hospital based, it 
an indication that primary Rubella infection is 
presented to the hospital and hospital personnel 
might be at risk of acquiring infections. This 
supports the fact that emphasis should be placed on 
vaccinating susceptible hospital personnel 
especially women. 
The remaining 16 IgM seropositive participants had 
high-avidity Rubella IgG implying reinfection or 
persistent IgG in 5.6% women of reproductive age. 
Although reinfection poses approximately 8% risk ( 
symptomatic reinfection may have a greater risk ) of 
foetal infection following asymptomatic reinfection 
in the first 16 weeks of pregnancy, foetal 
malformations are rare (22). However, the 
distinction between reinfection and persistent 
Rubella infection could not be made in this study as 
further assay is required.  
Seroprevalence of Rubella virus in different 
communities is notably related to age (23). In this 
study, the influence of age on the seroprevalence of 
Rubella IgM among women of reproductive age 
was assessed. Rubella IgM Seropositivity rate 
increased with increasing age, but this was not 
statistically significant. Studies by Dayan et al  and 
Palihawadana  et al  found significant increasing 
seroprevalence of Rubella with increasing age (24, 
25). Study by among Turkish women however, 
reported no significant relationship between age 
and Rubella seroprevalence (26). 
Although fever and rash are known symptoms of 
rubella infections, only three (8.7%) of the 23 
participants with rubella specific IgM antibody had 
a recent history of fever and rash. There was no 
significant association between Rubella IgM 
seropositivity and recent history of fever and rash. 
(p=0.776). This may be due to the fact that more 
than 50% of rubella infection may be asymptomatic 
(8).  However, Pennap et al reported significant 
association between rubella infection and fever and 
rash (14). 
Seroprevalence of Rubella virus in different 
communities is notably related to age, and 
socioeconomic status (23). Socio-economic class 
(SEC) is an economic and sociological combined 
total measure of an individual based on the level of 
education, occupation and family income (27). In 
this study, the influence of highest level of 
education and occupation on the IgM 
seroprevalence of rubella among women of 
reproductive age was assessed. 
The highest number of recent rubella infection 
observed among students could be due to high 
exposure with a wider population. The participants 
whose highest level of education was secondary 
education also recorded the highest number of 
recent rubella infection. This is similar to study by 
Eleazu et al (28). The rubella IgM seroprevalence 
however had no significant association with level of 
education and occupation of participants. 
 
CONCLUSION 
Prevalence of recent rubella infection among 
women of reproductive age in Ilorin was 8.1%. The 
seroprevalence of recent primary rubella infection 
was 2.5%. No significant association was found 
between age and rubella IgM seropositivity. There 
is therefore a need for rubella vaccination among 
women of childbearing age when rubella 
vaccination is eventually introduced in the national 
programme on immunization (If the WHO 
recommended 80% measles vaccination coverage 
before rubella vaccine introduction is achieved). 
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